Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04379700 · ClinicalTrials.gov registry record · NA
Geniculate Artery Embolization for Treatment of Osteoarthritis
A NA study of Osteoarthritis, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT04379700: Completed NA study of Osteoarthritis, sponsored by NYU Langone Health.
NCT04379700 is a NA study of Osteoarthritis that has completed, run by NYU Langone Health. The registered enrollment target is 38 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04379700, a NA study of Osteoarthritis, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
Single-arm, single-center, no sham or placebo, prospective pilot trial designed to evaluate the feasibility and safety of transcatheter arterial embolization in patients with mild to moderate radiographic knee OA. Eligible participants will receive geniculate artery embolization using Embozene™ Color-Advanced Microspheres. Patients will be followed up for a total of 12 months.
Primary Outcome
The WOMAC questionnaire includes 24 questions on daily activities. The Pain Score subsection includes five questions regarding pain (pain during walking, stair climbing, nocturnal, rest, weight bearing); each question is scored on a Likert scale as follow: 0 for no pain, 1 for mild, 2 for moderate, 3 for severe, and 4 for extreme pain. The total score is the sum of responses and ranges from 0-20; higher scores indicate greater pain.
Conditions Studied
Interventions
- PROCEDURE Transcatheter arterial embolization
- DEVICE Embozene™ Microspheres
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2025-03-12 |
| Phase | NA |
What the finished NCT04379700 record still lists
NCT04379700 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Transcatheter arterial embolization is the first listed.
NCT04379700 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04379700 about?
NCT04379700 is a clinical study titled "Geniculate Artery Embolization for Treatment of Osteoarthritis". Single-arm, single-center, no sham or placebo, prospective pilot trial designed to evaluate the feasibility and safety of transcatheter arterial embolization in patients with mild to moderate radiographic knee OA. Eligible participants will receive geniculate artery embolization using Embozene™ Colo...
What is the current status of trial NCT04379700?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2020-12-01. Estimated completion is 2025-03-12.
What conditions does trial NCT04379700 study?
This clinical trial studies the following conditions: Osteoarthritis.
What interventions are being tested in trial NCT04379700?
The interventions under investigation include: Transcatheter arterial embolization (PROCEDURE), Embozene™ Microspheres (DEVICE).
Who is sponsoring clinical trial NCT04379700?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04379700 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04379700's enrollment target sits among peer trials
38 126th of 135 higher than 9 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients
RECRUITING · NA
-
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI